Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro.
about
Current status of safinamide for the drug portfolio of Parkinson's disease therapy.Pharmacokinetic/pharmacodynamic evaluation of rasagiline mesylate for Parkinson's disease.Clinical Pharmacokinetics and Pharmacodynamics of Safinamide.Categorization and association analysis of risk factors for adverse drug events.Switch from selegiline to rasagiline is beneficial in patients with Parkinson's disease.
P2860
Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effects of rasagiline, its met ...... at hippocampus slice in vitro.
@ast
Effects of rasagiline, its met ...... at hippocampus slice in vitro.
@en
type
label
Effects of rasagiline, its met ...... at hippocampus slice in vitro.
@ast
Effects of rasagiline, its met ...... at hippocampus slice in vitro.
@en
prefLabel
Effects of rasagiline, its met ...... at hippocampus slice in vitro.
@ast
Effects of rasagiline, its met ...... at hippocampus slice in vitro.
@en
P2860
P356
P1433
P1476
Effects of rasagiline, its met ...... at hippocampus slice in vitro.
@en
P2093
J A Hoffmann
P2860
P2888
P356
10.1186/1471-2210-11-2
P577
2011-02-21T00:00:00Z
P5875
P6179
1011918837